Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API

Cancer-related Molecular Pathways

20 та иш

  1. Investigation of Structural Mechanisms Underlying p53 Dysfunction Caused by 148 Missense Mutations Using AlphaFold3 and Molecular Dynamics Simulations

    Khondamir R Rustamov, Jamoliddin Razzokov, Artyom Y. Baev

    МақолаCancer-related Molecular PathwaysJournal of Chemical Information and Modeling20251 иқтибос
    ABI

  2. Molecular and clinical aspects of oropharyngeal squamous cell carcinoma associated with human papillomavirus

    D. Polatova, А. Yu. Madaminov

    МақолаHead and Neck Cancer StudiesHead and neck tumors (HNT)20211 иқтибос
    ABI

  3. Stem cell quality following irradiation: Comparison of 125IUdR uptake in the spleen and number and size of splenic colonies in bone marrow transfused, fatally irradiated mice.

    Takayoshi Inoue, E. P. Cronkite, G. E. HVBNER +2

    МақолаEffects of Radiation ExposureJournal of Radiation Research19840 иқтибос
    ABI

  4. Retinoblastoma in Uzbekistan.

    Tamara Mouratova

    МақолаOcular Oncology and TreatmentsPubMed20030 иқтибос
    ABI

  5. Gemcitabine Changes the Gene Expression in Human Pancreatic Cancer Cells: Search for New Therapeutic Molecular Targets

    Yoshiharu Motoo, Takeo Shimasaki, Toshinari Minamoto

    БобWnt/β-catenin signaling in development and cancerPancreatology20090 иқтибос
    ABI

  6. MD Simulations of the P53 oncoprotein structure: the effect of the Arg273→His mutation on the DNA binding domain

    Kholmirzo Kholmurodov, Ermuhammad Dushanov, Kenji Yasuoka

    МақолаCancer-related Molecular PathwaysAdvances in Bioscience and Biotechnology20110 иқтибос
    ABI

  7. Rubijervine

    Shakhnoza S. Azimova, Marat S. Yunusov

    БобAxon Guidance and Neuronal Signaling20120 иқтибос
    ABI

  8. Expression of P53 and Bcl-2 in Colorectal Cancer with Liver Metastases

    Hurshid Islamov, Navruzov Sn, S.B. Abdujapparov

    МақолаCancer-related Molecular PathwaysAnnals of Oncology20130 иқтибос
    ABI

  9. Searching of a Different Approach for Target Therapy of Papillary Thyroid Cancer

    Artykbaeva Gm

    МақолаThyroid Cancer Diagnosis and TreatmentGlobal Journal of Endocrinological Metabolism20180 иқтибос
    ABI

  10. The Role Of The Pro47ser Polymorphism Of The Tr53 Gene In Predisposition To Breast Cancer

    Nodirjon Shakhriqulovich Avezov, Dilbar Abdullaevna Kodirova, Khakimov Golib Abdullevich +4

    МақолаCancer-related Molecular PathwaysThe American Journal of Medical Sciences and Pharmaceutical Research20200 иқтибос
    ABI

  11. Cancer - dysregulation of the cell cycle and transduction of cascade signals

    Akhmad Madaminov, A. I. Khasanov, Shuhrat Khatamov +6

    МақолаCancer-related Molecular PathwaysRomanian Journal of Rhinology20210 иқтибос
    ABI

  12. Emerging small-molecule inhibitors of ATM kinase targeting cancer therapy

    Ilma Shakeel, Yeshfa Zaidi, Varsha Gupta +5

    БобDNA Repair MechanismsElsevier eBooks20220 иқтибос
    ABI

  13. POSTER: ALL-253 Evaluation of Aberrant Expression of CD Markers in Acute Leukemia Cells

    Nawsherwan Mohammed, Lava Najim

    МақолаCancer-related Molecular PathwaysClinical Lymphoma Myeloma & Leukemia20230 иқтибос
    ABI

  14. VAV3 in human cancers: Mechanism and clinical implication

    Sulieman Ibraheem Shelash Al-Hawary, Ali Alsalamy, Reena Gupta +7

    Шарҳ мақолаUbiquitin and proteasome pathwaysPathology - Research and Practice20230 иқтибос
    ABI

  15. EPIGENETIC INACTIVATION OF TUMOR SUPPRESSOR GENES- MARKER FOR MONITORING THE EFFECTIVENESS OF THERAPY

    Dilbar Abdullaevna Kadirova, N.SH. AVEZOV, А. А. Ибрагимов +1

    МақолаEpigenetics and DNA MethylationGlobal Journal of Medical and Pharmaceutical Sciences20240 иқтибос
    ABI

  16. Retinoblastoma outcomes in Europe: a prospective analysis of 483 patients from 40 countries

    Richard Bowman, Mattan Arazi, Nathalie Cassoux +96

    МақолаOcular Oncology and TreatmentsEye20250 иқтибос
    ABI

  17. ASSOCIATION OF THE PRO72ARG (RS1042522) POLYMORPHISM OF THE TP53 GENE WITH THE DEVELOPMENT OF MYELOPROLIFERA-TIVE NEOPLASMS IN THE KHOREZM REGION

    Marguba Zhumaboeva, К. Т. Бобоев, Rustambek Matmurodov +1

    МақолаCancer-related Molecular PathwaysMedical science of Uzbekistan20250 иқтибос
    ABI

  18. Structure-driven design and precision translation of functionally diverse isatin-based CDK2 inhibitors: Advances in SAR, polypharmacology, and biomarker-guided cancer therapy

    Safia Obaidur Rab, A. Al-Shahrani, Lalji Baldaniya +9

    МақолаCancer-related Molecular PathwaysJournal of Molecular Structure20250 иқтибос
    ABI

  19. 1628 The First Comprehensive Genomic Landscape of Non-Small Cell Lung Carcinoma from Uzbekistan Reveals High TP53 Co-Mutations and Actionable Alterations in a 200-Patient Cohort

    Madina Jakhongirova, Mirzabek Shodmonov Isokul Ugli, Natalya Pak +4

    МақолаLung Cancer Treatments and MutationsLaboratory Investigation20260 иқтибос
    ABI

  20. Molecular docking insights into Calophyllum-derived chromanones as potential EGFR and STAT3 inhibitors in cervical cancer: A review

    Nur Nabilah Mohd Zaini, Wan Mohd Nuzul Hakimi Wan Salleh, Nurunajah Ab Ghani +4

    МақолаNatural Compound Pharmacology StudiesEdelweiss Applied Science and Technology20260 иқтибос
    ABI